REAGEN LOUGHRAN: Open Payments
NPI 1821277518 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 54 payments from 16 companies in 2025. Trend: 2023 $761 · 2024 $1,163 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $366 |
| Axsome Therapeutics, Inc. | 7 | $197 |
| AstraZeneca Pharmaceuticals LP | 4 | $195 |
| Teva Pharmaceuticals USA, Inc. | 5 | $193 |
| Corcept Therapeutics | 4 | $181 |
| Neurelis, Inc. | 1 | $95 |
| Indivior Inc. | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| Janssen Pharmaceuticals, Inc | 1 | $53 |
| Amgen Inc. | 3 | $47 |
Products named: Auvelity, Korlym, VRAYLAR, AUSTEDO XR, AIRSUPRA, VALTOCO, QULIPTA, MAVYRET.
Industry payments across KY — which companies pay providers there.
